Elior's Monthly Share Count Says Nothing. The Leverage Ratio Says Everything.

Every month Elior Group files a page of French boilerplate nobody reads. The July one, out on August 3, is the same ritual as June's: the number of shares, the gross total of voting rights, the net total, and a paragraph of legal code. As of June 30 the count was 253,611,809 shares, 251,021,586 voting rights net of the treasury shares. It is the most boring regulatory document a Paris-listed company can publish — and for Elior, that flat, steady share count is exactly why a retail investor should look twice.

The monthly statement is a tripwire. It exists so outsiders can watch for a change in who owns the company and how many votes they control. Elior's count barely moves because control of Elior barely moves: Derichebourg, the French industrial group, holds roughly 48.4% and has said it has no intention of launching a takeover bid. A twelve-figure share count, a controlling shareholder, and no hostile-takeover theater. The document tells you nothing changed. That is the point. The offscreen question is what those 253.6 million shares are actually priced against.

The short answer is a balance sheet that is nowhere near as calm as the share count. Elior is one of the world's biggest contract-catering and multiservices operators — the companies that run the cafeterias in offices, hospitals, airports, and schools, largely under long-term contracts. In fiscal 2024-2025 (twelve months ended September 30, 2025) it booked €6,150 million of revenue, about 73% of it from contract catering. It is a business of thin margins, heavy workforce, and cash that arrives in a steady drip, not in waves.

That scale hides the fact that this is a recovery stock that spent years in the red. For fiscal 2024-2025 Elior reported a net profit of €87 million — its first full-year profit since 2019 — and so loudly announced a return to form that it resumed its dividend. Management's own word for the year was "outstanding." Adjusted EBITA reached €202 million at a 3.3% margin, and it cut net debt by €144 million, pushing leverage down to 3.3x net debt to EBITDA from 3.8x. On paper, a clean inflection: profit, cash, and a dividend, all in one year.

That is the story the company wants believed. The first half of fiscal 2025-2026 is the number that resists it.

For the six months ended March 31, 2026, revenue rose only 1.3% organically to €3,179 million, and adjusted EBITA actually fell to €95 million from €132 million a year earlier — a 3% margin versus 4.1%. The group took a €25 million provision for a loss it now expects on a contract with an Italian rail operator, the result of a pricing dispute. Strip that exceptional item out and the underlying net result of €46 million was only slightly better than last year. Leverage did not fall; it rose, to 3.6x from 3.3x. On the conference call the company cut its full-year guidance for both growth and margin, then did it again: organic growth lowered to 1-2%, adjusted EBITA margin to about 3%, and the promised "deliveraging" target pushed out to roughly 3.5x net debt to EBITDA.

The Italian rail contract deserves a pause, because it is the kind of line a detective reads twice. A company in a recovery story books a one-time €25 million "loss at completion" on a single counterparty and calls it exceptional. That is a plausible accounting event — fixed-price contracts do go wrong, and a disputed rail job is a textbook case. But it is also the first concrete proof that the economics this recovery is built on are not as durable as advertised. When contract caterers compete for long concessions, they sometimes win by pricing the work too cheaply, and the shortfall surfaces years later as a finish-line provision. The question is not whether one rail contract is real pain. It is whether that €25 million is the exception or the preview.

This is where the shares, the debt, and the price converge into the actual investment case. Elior's market value at the end of August was only about €514 million. Against that stands a balance sheet carrying roughly 3.5x net debt to EBITDA — and a covenant on that debt at 4.5x. In plain terms, the equity is a small claim layered on top of a big pile of borrowed money. That changes the mathematics of any surprise. A miss on the margin target does not just cost a few points of profit; it eats into the gap between current leverage and the 4.5x covenant, which is the last thing a heavily-indebted caterer wants to demonstrate to its lenders. Conversely, if the recovery compounds — margins climbing back toward 4% and cash flowing as promised — the same leverage makes each incremental euro of profit worth far more to shareholders than it would be on an unlevered balance sheet. The stock is a leveraged option on whether this turnaround holds.

There is one more tell in the monthly paperwork. In February 2026 Elior's shareholders authorized a share buyback program with a maximum investment just over €253.6 million. A company that is simultaneously promising to deleverage, sitting at 3.5x net debt to EBITDA, and cutting its profit forecast is choosing to keep a buyback on the table. Buybacks reduce the very share count those monthly statements track — the count has stayed flat so far because the purchases to date have been small. It is a minor point, but in a recovery dressed up as financial discipline, it is the small contradiction worth flagging: capital that could be used to test the covenant gap is parked in a mandate to repurchase stock.

None of this makes Elior a fraud, and none of it should. The filings are coherent, the recovery is real, and a single disputed rail contract is a legitimate once-off. But the honest read is that the equity is being valued, at roughly half a billion euros, as if the downward guidance were already priced and the turnaround intact. The evidence ladder for the recovery story ended where H1 left it: a red flag in the form of one provision and two guidance cuts, not a corroborated collapse. Those annual losses before fiscal 2025 are real history, and 3.5x leverage is real exposure. What a buyer is paying for is the gap between a resilient recovery and the one that keeps slipping — and the monthly statement that will confirm it is not the share count, but the next full-year number in late November.